Perioperative adverse events in women over age 65 undergoing robot-assisted sacrocolpopexy

Introduction and hypothesis: Pelvic floor disorders are common among and disproportionately affect older women. There are limited data regarding perioperative adverse events in older women undergoing robot-assisted sacrocolpopexy (RASC) specifically. The aim of this study was to compare the rate of perioperative adverse events in younger (age <65 years) versus older (age >65 years) women who underwent RASC. Methods: We conducted a retrospective cohort study of women who underwent RASC between 2013 and 2018. Postoperative adverse events were categorized according to the Clavien–Dindo classification. Our primary outcome was the rate of intraoperative adverse events and postoperative adverse events with Clavien–Dindo grade II or greater. Outcomes were compared using univariate and multivariate analysis. Results: Of the 327 patients included in the study, 227 were <65 years of age and 100 were ≥65 years of age. Women ≥65 years of age had higher rates of hypertension, higher American Society of Anesthesiologist (ASA) class, and higher Charlson Comorbidity Index (CCI) scores compared with women <65 years of age; these were not associated with increased likelihood of adverse events. The overall rate of any perioperative adverse event was 18.3%. There was no statistically significant difference in the overall rate of perioperative adverse events between younger and older women (18.5% vs 18.0%, p = 0.91). Conclusions: There is no difference in rate of adverse events between women ≥65 years of age undergoing RASC and their younger counterparts.